Left atrial appendage closure: First in man with the 4th generation watchman device

Catheterization and Cardiovascular Interventions

Volumn 87, Issue 4, 2016, Pages 787-794

  Ledwoch, Jakob ^a   Franke, Jennifer ^a   Gonzaga, Maik ^a   Bertog, Stefan ^a   Braut, Annkathrin ^a   Hofmann, Ilona ^a   Vaskelyte, Laura ^a   Gafoor, Sameer ^a   Reddy, Vivek ^b   Sievert, Horst ^a  

^a CardioVascular Center CVC   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

atrial fibrillation; left atrial appendage closure; stroke prevention

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL ARTICLE; DEVICE SAFETY; FEASIBILITY STUDY; FEMALE; FLUOROSCOPY; GROIN HEMATOMA; HUMAN; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; MALE; MORTALITY; PERICARDIAL EFFUSION; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; ADVERSE EFFECTS; COMPLICATION; DEVICES; DIAGNOSTIC IMAGING; EVALUATION STUDY; FOLLOW UP; HEART ATRIUM APPENDAGE; HEART CATHETERIZATION; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; PATHOPHYSIOLOGY; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; STROKE; TIME FACTOR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; STROKE; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84941299509     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.26238     Document Type: Article

References (20)

1. Camm AJ, Lip GY, Caterina De, P, et al., 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33: 2719-2747.
2. Park JW, Bethencourt A, Sievert H, et al., Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: Initial European experience. Catheter Cardiovasc Interv 2011; 77: 700-706.
3. Urena M, Rodes-Cabau J, Freixa X, et al., Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. J Am Coll Cardiol 2013; 62: 96-102.
4. Holmes DR Jr, Kar S, Price MJ, et al., Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. J Am Coll Cardiol 2014; 64: 1-12.
5. Holmes DR, Reddy VY, Turi ZG, et al, Investigators PA. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial. Lancet 2009; 374: 534-542.
6. Reddy VY, Doshi SK, Sievert H, et al, Investigators PA. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation 2013; 127: 720-729.
7. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S., Safety of percutaneous left atrial appendage closure: Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011; 123: 417-424.
8. Reddy VY, Mobius-Winkler S, Miller MA, et al., Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: The ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol 2013; 61: 2551-2556.
9. Tzikas A, Shakir S, Gafoor S, et al., Left atrial appendage occlusion for stroke prevention in atrial fibrillation: Multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention 2015; 10. doi: 10.4244/EIJY15M01-06. [Epub ahead of print]
10. Reddy VY, Sievert H, Halperin J, et al, Committee PAS, Investigators. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: A randomized clinical trial. JAMA 2014; 312: 1988-1998.
11. Habib G, Hoen B, Tornos P, et al, Guidelines ESCCfP. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30: 2369-2413.
12. Blackshear JL, Odell JA., Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996; 61: 755-759.
13. Pison L, Potpara TS, Chen J, et al, Scientific Initiative Committee EHRA. Left atrial appendage closure-indications, techniques, and outcomes: Results of the European Heart Rhythm Association Survey. Europace 2015; 17: 642-646.
14. Bayard YL, Omran H, Neuzil P, et al., PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: Results from the European PLAATO study. EuroIntervention 2010; 6: 220-226.
15. Ostermayer SH, Reisman M, Kramer PH, et al., Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: Results from the international multi-center feasibility trials. J Am Coll Cardiol 2005; 46: 9-14.
16. O'Brien J, Al-Hassan D, Ng J, et al., Three-dimensional assessment of left atrial appendage orifice geometry and potential implications for device closure. Int J Cardiovasc Imaging 2014; 30: 819-823.
17. Viles-Gonzalez JF, Kar S, Douglas P, et al., The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: A PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol 2012; 59: 923-929.
18. Park JW., Results of the AMPLATZER Cardiac Plug European Multicenter Observational Study. Presented at the Transcatheter Cardiovascular Therapeutics Conference, Miami; 2012.
19. Bai R, Horton RP, DI Biase L, et al., Intraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN device: A single center experience. J Cardiovasc Electrophysiol 2012; 23: 455-461.
20. Freixa X, Tzikas A, Sobrino A, et al., Left atrial appendage closure with the Amplatzer Cardiac Plug: Impact of shape and device sizing on follow-up leaks. Int J Cardiol 2013; 168: 1023-1027.